National Recognition - UMGCCC

The University of Maryland Marlene and Stewart Greenebaum Cancer (UMGCCC) has attained national recognition for excellence in cancer treatment and research. 

As a National Cancer Institute (NCI)-designated comprehensive cancer center, UMGCCC is among the top tier of cancer centers in the country.

The following are a few more of the distinctions earned by our center to date:

• In 2024, UMGCCC nationally ranked as a best cancer care hospital by U.S. News and World Report.
• Magnet designation by the American Nurses credentialing Center (ANCC)

• Accreditation by the American College of Surgeons, Commission on Cancer

• National Accreditation Program for Breast Centers (NAPBC) for our breast program
• Center of Excellence for treatment in Myelodysplastic Syndromes (MDS) by the Myelodysplastic Syndromes Foundation
• Foundation for the Accreditation of Cellular Therapy (FACT) accreditation for blood and marrow transplant based on meeting rigorous national standards and based on the latest knowledge of the field of cellular therapy product transplantation
• Nationally recognized as a Center of Excellence for meeting or exceeding aggressive quality of care and patient survival benchmarks by the following health insurance companies and national transplant networks:
  • Aetna Institutes of Excellence
  • Blue Distinction Centers
  • CIGNA Life Source Transplant Network
  • Emerging Technology Solutions Transplant Network
  • Interlink Health Services Transplant Network
  • Humana National Transplant Network
  • OptumHealth Transplant Network
  • OptumHealth Transplant Resource Services Network
  • OptumHealth Cellular Immunotherapy Preferred Provider Network